Fabrication of Gentamicin-Loaded Hydroxyapatite/Collagen Bone-Like Nanocomposite for Anti-Infection Bone Void Fillers.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jan 2020
Historique:
received: 24 09 2019
revised: 09 01 2020
accepted: 09 01 2020
entrez: 19 1 2020
pubmed: 19 1 2020
medline: 6 10 2020
Statut: epublish

Résumé

A gentamicin-loaded hydroxyapatite/collagen bone-like nanocomposite (GNT-HAp/Col) was fabricated and evaluated for its absorption-desorption properties, antibacterial efficacy, and cytotoxicity. The hydroxyapatite/collagen bone-like nanocomposite (HAp/Col) powder was mixed with gentamicin sulfate (GNT) in phosphate-buffered saline (PBS) at room temperature. After 6 h mixing, the GNT adsorption in all conditions reached plateau by Langmuir's isotherm, and maximum GNT adsorption amount was 34 ± 7 μg in 250 μg/mL GNT solution. Saturated GNT-loaded HAp/Col powder of 100 mg was soaked in 10 mL of PBS at 37 °C and released all GNT in 3 days. A shaking culture method for a GNT extraction from the GNT-HAp/Col and an inhibition zone assay for the GNT-HAp/Col compact showed antibacterial efficacy to

Identifiants

pubmed: 31952242
pii: ijms21020551
doi: 10.3390/ijms21020551
pmc: PMC7013509
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bone Substitutes 0
Buffers 0
Gentamicins 0
Phosphates 0
Powders 0
Collagen 9007-34-5
Durapatite 91D9GV0Z28

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Chirurg. 1972 Oct;43(10):446-53
pubmed: 5084870
Semin Immunopathol. 2011 May;33(3):295-306
pubmed: 21603890
J Biomed Mater Res B Appl Biomater. 2016 Nov;104(8):1632-1642
pubmed: 26332762
Adv Drug Deliv Rev. 2003 Nov 28;55(12):1679-98
pubmed: 14623407
J Pharm Pharmacol. 1994 Sep;46(9):718-24
pubmed: 7837040
Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):3583-91
pubmed: 23910253
Clin Microbiol Infect. 2001 Jan;7(1):28-31
pubmed: 11284941
J Orthop Sci. 2016 May;21(3):373-80
pubmed: 26961287
Chem Soc Rev. 2006 Sep;35(9):780-9
pubmed: 16936926
Biomaterials. 2001 Jul;22(13):1705-11
pubmed: 11396873
JAMA Surg. 2017 Aug 1;152(8):784-791
pubmed: 28467526
Acta Orthop Scand. 2000 Dec;71(6):625-9
pubmed: 11145392
Int J Nanomedicine. 2016 Mar 10;11:977-90
pubmed: 27022263
Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):5008-18
pubmed: 24094218
J Biomed Mater Res A. 2015 Feb;103(2):782-90
pubmed: 24825292
Eur J Pharm Biopharm. 2015 Oct;96:264-71
pubmed: 26297104

Auteurs

Sho Oshima (S)

Major in Industrial Science, Graduate School of Science and Engineering, Ibaraki University, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 316-8511, Japan.
Bioceramics Group, Research Center for Functional Materials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.

Taira Sato (T)

Bioceramics Group, Research Center for Functional Materials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.
Department of Applied Chemistry, Graduate School of Science and Technology, Meiji University, 1-1-1 Higashimita, Tama, Kawasaki, Kanagawa 214-8571, Japan.

Michiyo Honda (M)

Department of Applied Chemistry, School of Science and Technology, Meiji University, 1-1-1 Higashimita, Tama, Kawasaki, Kanagawa 214-8571, Japan.

Yasushi Suetsugu (Y)

Bioceramics Group, Research Center for Functional Materials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.

Kazuhide Ozeki (K)

Major in Mechanical Systems Engineering, Graduate School of Science and Engineering, Ibaraki University, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 316-8511, Japan.

Masanori Kikuchi (M)

Bioceramics Group, Research Center for Functional Materials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH